HGH frag 176-191

C

HGH fragment 176-191 is the C-terminal 16-amino-acid fragment of human growth hormone, discussed around fat-metabolism research but not interchangeable with full HGH or AOD9604.

What is HGH frag 176-191?

HGH fragment 176-191 is the C-terminal 16-amino-acid fragment of human growth hormone, discussed around fat-metabolism research but not interchangeable with full HGH or AOD9604.

HGH frag 176-191 dosage snapshot

Route
subQ
Dose range
250-500 mcg
Frequency
daily
Duration
8-12 weeks

Based on reported research sources; not a dosing instruction.

Potential benefits

  • Weight management
  • Appetite control
  • Glucose control
  • Metabolic health
  • Body composition

Safety profile

Unknown risk
  • Common: Route-specific irritation or tolerability issues may be reported depending on the compound.
  • Less common: Headache, fatigue, appetite changes, or GI discomfort can appear in community or study contexts.
  • Caution: Risk depends on dose, route, study model, duration, compound quality, and whether human data exists.

Storage and handling

Store according to product-label instructions and batch handling notes. Lyophilized research peptides are commonly kept dry, protected from light, and handled with clean laboratory technique.

Related peptides